US 6,332,863 B1Grant
Heart wall tension reduction kit
Issue Date:2001-12-25
•39 Claims
•8 Drawing Sheets
Abstract
An apparatus for treatment of a failing heart by reducing the wall tension therein. In one embodiment, the apparatus includes a tension member for drawing at least two walls of a heart chamber toward each other. Methods for placing the apparatus on the heart are also provided.
Metadata
Assignee
- Myocor, Inc.
Inventors
- Cyril J. Schweich, Jr.
- Todd J. Mortier
Application Information
Application Number:US 09/697,596
Filing Date:2000-10-27
Priority Date:1997-01-02
Art Unit:7
Classifications
IPC:
A61F 200A61B 1712A61M 3100
Field of Search:
600 37601 11623 3623 11128897128898
Patent Drawings (8 sheets)
Description
Cross Reference to Related Application
[0002] This is a continuation of application Ser. No. 09/543,155, filed Apr. 4, 2000, now U.S. Pat. No. 6,165,120 which is a continuation of application Ser. No. 09/224,349, filed Jan. 4, 1999, now U.S. Pat. No. 6,165,119, which is a division of application Ser. No. 08/933,456, filed Sep. 18, 1997, now U.S. Pat. No. 5,961,440, which is a continuation-in-part of application Ser. No. 08/778,277, filed Jan. 2, 1997, now U.S. Pat. No. 6,050,936, each of these references being incorporated herein by reference.
Field of the Invention
[0003] The present invention pertains to the field of apparatus for treatment of a failing heart. In particular, the apparatus of the present invention is directed toward reducing the wall stress in the failing heart.
Background of the Invention
[0004] The syndrome of heart failure is a common course for the progression of many forms of heart disease. Heart failure may be considered to be the condition in which an abnormality of cardiac function is responsible for the inability of the heart to pump blood at a rate commensurate with the requirements of the metabolizing tissues, or can do so only at an abnormally elevated filling pressure. There are many specific disease processes that can lead to heart failure with a resulting difference in pathophysiology of the failing heart, such as the dilatation of the left ventricular chamber. Etiologies that can lead to this form of failure include idiopathic cardiomyopathy, viral cardiomyopathy, and ischemic cardiomyopathy.
[0005] The process of ventricular dilatation is generally the result of chronic volume overload or specific damage to the myocardium. In a normal heart that is exposed to long term increased cardiac output requirements, for example, that of an athlete, there is an adaptive process of slight ventricular dilation and muscle myocyte hypertrophy. In this way, the heart fully compensates for the increased cardiac output requirements. With damage to the myocardium or chronic volume overload, however, there are increased requirements put on the contracting myocardium to such a level that this compensated state is never achieved and the heart continues to dilate.
[0006] The basic problem with a large dilated left ventricle is that there is a significant increase in wall tension and/or stress both during diastolic filling and during systolic contraction. In a normal heart, the adaptation of muscle hypertrophy (thickening) and ventricular dilatation maintain a fairly constant wall tension for systolic contraction. However, in a failing heart, the ongoing dilatation is greater than the hypertrophy and the result is a rising wall tension requirement for systolic contraction. This is felt to be an ongoing insult to the muscle myocyte resulting in further muscle damage. The increase in wall stress is also true for diastolic filling. Additionally, because of the lack of cardiac output, there is generally a rise in ventricular filling pressure from several physiologic mechanisms. Moreover, in diastole there is both a diameter increase and a pressure increase over normal, both contributing to higher wall stress levels. The increase in diastolic wall stress is felt to be the primary contributor to ongoing dilatation of the chamber.
[0007] Prior art treatments for heart failure fall into three generally categories. The first being pharmacological, for example, diuretics. The second being assist systems, for example, pumps. Finally, surgical treatments have been experimented with, which are described in more detail below.
[0008] With respect to pharmacological treatments, diuretics have been used to reduce the workload of the heart by reducing blood volume and preload. Clinically, preload is defined in several ways including left ventricular end diastolic pressure (LVEDP), or left ventricular end diastolic volume (LVEDV) Physiologically, the preferred definition is the length of stretch of the sarcomere at end diastole. Diuretics reduce extra cellular fluid which builds in congestive heart failure patients increasing preload conditions. Nitrates, arteriolar vasodilators, angiotensin converting enzyme inhibitors have been used to treat heart failure through the reduction of cardiac workload through the reduction of afterload. Afterload may be defined as the tension or stress required in the wall of the ventricle during ejection. Inotropes like digoxin are cardiac glycosides and function to increase cardiac output by increasing the force and speed of cardiac muscle contraction. These drug therapies offer some beneficial effects but do not stop the progression of the disease.
[0009] Assist devices include mechanical pumps and electrical stimulators. Mechanical pumps reduce the load on the heart by performing all or part of the pumping function normally done by the heart. Currently, mechanical pumps are used to sustain the patient while a donor heart for transplantation becomes available for the patient. Electrical stimulation such as bi-ventricular pacing have been investigated for the treatment of patients with dilated cardiomyopathy.
[0010] There are at least three surgical procedures for treatment of heart failure: 1) heart transplant; 2) dynamic cardiomyoplasty; and 3) the Batista partial left ventriculectomy. Heart transplantation has serious limitations including restricted availability of organs and adverse effects of immunosuppressive therapies required following heart transplantation. Cardiomyoplasty includes wrapping the heart with skeletal muscle and electrically stimulating the muscle to contract synchronously with the heart in order to help the pumping function of the heart. The Batista partial left ventriculectomy includes surgically remodeling the left ventricle by removing a segment of the muscular wall. This procedure reduces the diameter of the dilated heart, which in turn reduces the loading of the heart. However, this extremely invasive procedure reduces muscle mass of the heart.
Summary of the Invention
[0011] The present invention pertains to a non-pharmacological, passive apparatus and method for the treatment of a failing heart. The device is configured to reduce the tension in the heart wall. It is believed to reverse, stop or slow the disease process of a failing heart as it reduces the energy consumption of the failing heart, decreases isovolumetric contraction, increases sarcomere shortening during contraction and increases isotonic shortening which in turn increases stroke volume. The device reduces wall tension during diastole and systole.
[0012] In one embodiment, the apparatus includes a tension member for drawing at least two walls of the heart chamber toward each other to reduce the radius or area of the heart chamber in at least one cross sectional plane. The tension member has anchoring members disposed at opposite ends for engagement with the heart or chamber wall.
[0013] In another embodiment, the apparatus includes a compression member for drawing at least two walls of a heart chamber toward each other. In one embodiment, the compression member includes a balloon. In another embodiment of the apparatus, a frame is provided for supporting the compression member.
[0014] Yet another embodiment of the invention includes a clamp having two ends biased toward one another for drawing at least two walls of a heart chamber toward each other. The clamp includes at least two ends having atraumatic anchoring member diposed thereon for engagement with the heart or chamber wall.
[0015] In yet another embodiment, a heart wall tension reduction apparatus is provided which includes a first tension member having two oppositely disposed ends and first and second elongate anchor members. A second tension member can be provided. One of the elongate anchors may be substituted for by two smaller anchors.
[0016] In an alternate embodiment of the heart wall tension reduction apparatus, an elongate compression member can be provided. First and second elongate lever members preferably extend from opposite ends of the compression member. A tension member extends between the first and second lever members.
[0017] The compression member of the above embodiment can be disposed exterior to, or internally of the heart. The tension member extends through the chamber or chambers to bias the lever members toward the heart.
[0018] In yet another embodiment of a heart wall tension reduction apparatus in accordance with the present invention, a rigid elongate frame member is provided. The frame member can extend through one or more chambers of the heart. One or more cantilever members can be disposed at opposite ends of the frame member. Each cantilever member includes at least one atraumatic pad disposed thereon. The atraumatic pads disposed at opposite ends of the frame member can be biased toward each other to compress the heart chamber.
[0019] One method of placing a heart wall tension apparatus or splint on a human heart includes the step of extending a hollow needle through at least one chamber of the heart such that each end of the needle is external to the chamber. A flexible leader is connected to a first end of a tension member. A second end of the tension member is connected to an atraumatic pad. The leader is advanced through the needle from one end of the needle to the other. The leader is further advanced until the second end of the tension member is proximate the heart and the first end of the tension member is external to the heart. A second atraumatic pad is connected to the first end of the tension member such that the first and second atraumatic pads engage the heart.
[0020] An alternate method of placing the heart wall tension reduction apparatus on the heart includes the step of extending a guide member through at least one chamber of the heart such that each end of the guide member is external to the chamber. A tension member for use in this method has at least one lumen extending through at least a portion of the member. The guide member is placed in the lumen. The tension member is advanced over the guide member such that a first end of the tension member is disposed to one side of and external to the heart and a second end of the tension member is disposed to an opposite side of and external to the heart. A first atraumatic pad is connected to one end of the tension member and a second atraumatic pad is connected to the opposite end of the tension member.
[0021] Yet another method of placing a heart wall tension apparatus on a heart includes the step of extending a needle having a flexible tension member releasably connected thereto through at least one chamber of the heart such that opposite ends of the tension member are external to the chamber and exposed on opposite sides of the chamber. The needle is removed from the tension member. Then first and second atraumatic pads are connected to the tension member at opposite ends of the tension member.
Brief Description of the Drawings
[0022] FIG. 1 is a transverse cross-section of the left and right ventricles of a human heart showing the placement of a splint in accordance with the present invention;
[0023] FIG. 2 is a transverse cross-section of the left and right ventricles of a human heart showing the placement of a balloon device in accordance with the present invention;
[0024] FIG. 3 is a transverse cross-section of the left and right ventricles of a human heart showing the placement of an external compression frame structure in accordance with the present invention;
[0025] FIG. 4 is a transvere cross-section of the left and right ventricles of a human heart showing a clamp in accordance with the present invention;
[0026] FIG. 5 is a transverse cross-section of the left and right ventricles of a human heart showing a three tension member version of the splint of FIG. 1;
[0027] FIG. 6 is a transverse cross-section of the left and right ventricles of a human heart showing a four tension member version of the splint shown in FIG. 1;
[0028] FIG. 7 is a vertical cross-sectional view of the left ventricle of a human heart showing an alternate version of the splint in accordance with the present invention;
[0029] FIG. 8 is an end of the splint shown in FIG. 7;
[0030] FIG. 9 is a vertical cross-sectional view of a chamber of a human heart showing another alternative embodiment of the splint in accordance with the present invention;
[0031] FIG. 10 is a vertical cross-section of a chamber of a human heart showing another alternative configuration of splints in accordance with the present invention;
[0032] FIG. 11 is a vertical cross-sectional view of a chamber of a human heart showing another embodiment of a splint in accordance with the present invention;
[0033] FIG. 12 is a vertical cross-sectional view of a chamber of a human heart showing another embodiment of the splint in accordance with the present invention;
[0034] FIG. 13 is a vertical cross-sectional view of a chamber of a human heart showing a compression member version of the splint in accordance with the present invention;
[0035] FIG. 14 is a vertical cross-sectional view of a chamber of a human heart showing another version of the splint shown in FIG. 13;
[0036] FIG. 15 is a vertical cross-sectional view of a chamber of a human heart showing a frame member version of the splint in accordance with the present invention;
[0037] FIG. 16 is an end view of the splint of FIG. 15;
[0038] FIG. 17 is a vertical cross-section of the left ventricle and atrium, the left ventricle having scar tissue;
[0039] FIG. 18 is a vertical cross-section of the heart of FIG. 7 showing the splint of FIG. 1 drawing the scar tissue toward the opposite wall of the left ventricle;
[0040] FIG. 19 is a vertical cross-section of the left ventricle and atrium of a human heart showing a version of the splint of FIG. 1 having an elongate anchor bar;
[0041] FIG. 20 is a side view of an undeployed hinged anchor member;
[0042] FIG. 21 is a side view of a deployed hinged anchor member of FIG. 10;
[0043] FIG. 22 is a cross-sectional view of an captured ball anchor member;
[0044] FIG. 23 is a perspective view of a cross bar anchor member;
[0045] FIG. 24 is a vertical cross-sectional view of a chamber of a human heart showing a needle used for placement of splint in accordance with the present invention;
[0046] FIG. 25 is a view of the heart and needle of FIG. 24 showing a tension member being placed in the heart;
[0047] FIG. 26 is a view of the heart shown in FIG. 24 wherein oppositely disposed anchor pads are being joined by a tension member;
[0048] FIG. 27 is a view of the heart of FIG. 24, wherein two oppositely disposed anchor pads have been joined by two tension members;
[0049] FIG. 28 is a view of a tension member having a lumen extending therethrough;
[0050] FIG. 29 is a view of a tension member having lumens extending therethrough;
[0051] FIG. 30 is a vertical cross-sectional view of a chamber of the heart and two pads, and a needle extending therethrough;
[0052] FIG. 31 is a vertical cross-sectional view of a chamber of the heart showing a guidewire extending therethrough;
[0053] FIG. 32 is a view of the heart of FIG. 31, and two pads, and a guidewire extending therethrough;
[0054] FIG. 33 is a vertical cross-sectional view of a chamber of the heart showing a needle connected to a tension member being inserted into the chamber;
[0055] FIG. 34 is a vertical cross-sectional view of a chamber of a heart showing two anchors connected by a tension member;
[0056] FIG. 35 is a vertical cross-sectional view of a chamber of the heart, showing a band surrounding the heart;
[0057] FIG. 36 is a idealized cylindrical model of a left ventricle of a human heart;
[0058] FIG. 37 is a splinted model of the left ventricle of FIG. 14;
[0059] FIG. 38 is a transverse cross-sectional view of FIG. 15 showing various modeling parameters;
[0060] FIG. 39 is a transverse cross-section of the splinted left ventricle of FIG. 15 showing a hypothetical force distribution; and
[0061] FIG. 40 is a second transverse cross-sectional view of the model left ventricle of FIG. 15 showing a hypothetical force distribution.
Detailed Description of the Invention
[0062] Referring now to the drawings wherein like reference numerals refer to like elements throughout the several views, FIG. 1 shows a transverse cross-section of a left ventricle 10 and a right ventricle 12 of a human heart 14. Extending through the left ventricle is a splint 16 including a tension member 18 and oppositely disposed anchors 20. Splint 16 as shown in FIG. 1 has been positioned to draw opposite walls of left ventricle 10 toward each other to reduce the “radius” of the left ventricular cross-section or the cross-sectional area thereof to reduce left ventricular wall stresses. It should be understood that although the splint 16 and the alternative devices disclosed herein are described in relation to the left ventricle of a human heart, these devices could also be used to reduce the radius or cross-sectional area of the other chambers of a human heart in transverse or vertical directions, or at an angle between the transverse and vertical.
[0063] FIG. 2 discloses an alternate embodiment of the present invention, wherein a balloon 200 is deployed adjacent the left ventricle. The size and degree of inflation of the balloon can be varied to reduce the radius or cross-sectional area of left ventricle 10 of heart 14.
[0064] FIG. 3 shows yet another alternative embodiment of the present invention deployed with respect to left ventricle 10 of human heart 14. Here a compression frame structure 300 is engaged with heart 14 at atraumatic anchor pads 310. A compression member 312 having an atraumatic surface 314 presses against a wall of left ventricle 10 to reduce the radius or cross-sectional area thereof.
[0065] FIG. 4 is a transverse cross-sectional view of human heart 14 showing yet another embodiment of the present invention. In this case a clamp 400 having atraumatic anchor pads 410 biased toward each other is shown disposed on a wall of left ventricle 10. Here the radius or cross-sectional area of left ventricle 10 is reduced by clamping off the portion of the wall between pads 410. Pads 410 can be biased toward each other and/or can be held together by a locking device.
[0066] Each of the various embodiments of the present invention disclosed in FIGS. 1-4 can be made from materials which can remain implanted in the human body indefinitely. Such biocompatible materials are well-known to those skilled in the art of clinical medical devices.
[0067] FIG. 5 shows an alternate embodiment of the splint of FIG. 1 referred to in FIG. 5 by the numeral 116. The embodiment 116 shown in FIG. 5 includes three tension members 118 as opposed to a single tension member 18 as shown in FIG. 1. FIG. 6 shows yet another embodiment of the splint 216 having four tension members 218. It is anticipated that in some patients, the disease process of the failing heart may be so advanced that three, four or more tension members may be desirable to reduce the heart wall stresses more substantially than possible with a single tension member as shown in FIG. 1.
[0068] FIG. 7 is a partial vertical cross-section of human heart 14 showing left ventricle 10. In FIG. 7, another splint embodiment 316 is shown having a tension member 318 extending through left ventricle 10. On opposite ends of tension member 318 are disposed elongate anchors or pads 320. FIG. 8 is an end view of tension member 318 showing elongate anchor 320.
[0069] FIG. 9 shows another embodiment of a splint 416 disposed in a partial vertical cross-section of human heart 14. Splint 416 includes two elongate anchors or pads 420 similar to those shown in FIGS. 7 and 8. In FIG. 9, however, two tension members 418 extend through left ventricle 10 to interconnect anchors 420 on opposite sides of heart 14.
[0070] FIG. 10 is a vertical cross section of heart 14 showing left ventricle 10. In this case, two splints 16 are disposed through left ventricle 10 and vertically spaced from each other to resemble the configuration of FIG. 9.
[0071] FIG. 11 is a vertical cross sectional view of the left ventricle of heart 14. Two alternate embodiment splints 516 are shown extending through left ventricle 10. Each splint 516 includes two tension members 518 interconnecting two anchors or pads 520.
[0072] FIG. 12 is yet another vertical cross sectional view of left ventricle 10 of heart 14. An alternate embodiment 616 of the splint is shown extending through left ventricle 10. Splint 616 includes an elongate anchor pad 620 and two shorter anchors or pads 621. Splint 616 includes two tension members 618. Each tension member 618 extends between anchors 620 and respective anchors 621.
[0073] FIG. 13 is a vertical cross sectional view of left ventricle 10 of heart 14. A splint 50 is shown disposed on heart 14. Splint 50 includes a compression member 52 shown extending through left ventricle 10. Opposite ends of compression member 52 are disposed exterior to left ventricle 10. Lever members 54 extend from each end of compression member 52 upwardly along the exterior surface of ventricle 10. A tension member 56 extends between lever members 54 to bias lever members 54 toward heart 14 to compress chamber 10.
[0074] Compression member 52 should be substantially rigid, but lever members 54 and to some degree compression member 52 should be flexible enough to allow tension member 56 to bias lever members 54 toward heart 14. Alternately, lever members 54 could be hinged to compression member 52 such that lever members 54 could pivot about the hinge when biased toward heart 14 by tension member 56.
[0075] FIG. 14 shows an alternate embodiment 156 of the splint shown in FIG. 13. In this case lever members 154 are longer than members 54 as compression member 152 of splint 150 has been disposed to the exterior of left ventricle 10.
[0076] FIG. 15 is a vertical cross sectional view of left ventricle 10 of heart 14. An alternate embodiment 250 of the splint is shown on heart 14. A preferably relatively rigid frame member 256 extends through ventricle 10. Disposed on opposite ends of frame 250 are cantilever member 254. Disposed on cantilever members 254 are atraumatic pads 258. Cantilever members 254 can be positioned along frame member 256 such that atraumatic pads 258 press against heart 14 to compress chamber 10. FIG. 16 is an end view of frame member 256 showing cantilever members 254 and pads 258.
[0077] It should be understood that each of the embodiments described above should be formed from suitable biocompatible materials known to those skilled in the art. The tension members can be formed from flexible or relatively more rigid material. The compression members and frame member should be formed from generally rigid material which may flex under load, but generally hold its shape.
[0078] FIG. 17 is a partial vertical cross-section of human heart 14 showing left ventricle 10 and left atrium 22. As shown in FIG. 7, heart 14 includes a region of scar tissue 24 associated with an aneurysm or ischemia. As shown in FIG. 7, the scar tissue 24 increases the radius or cross-sectional area of left ventricle 10 in the region affected by the scar tissue. Such an increase in the radius or cross-sectional area of the left ventricle will result in greater wall stresses on the walls of the left ventricle.
[0079] FIG. 18 is a vertical cross-sectional view of the heart 14 as shown in FIG. 7, wherein a splint 16 has been placed to draw the scar tissue 24 toward an opposite wall of left ventricle 10. As a consequence of placing splint 16, the radius or cross-sectional area of the left ventricle affected by the scar tissue 24 is reduced. The reduction of this radius or cross-sectional area results in reduction in the wall stress in the left ventricular wall and thus improves heart pumping efficiency.
[0080] FIG. 9 is a vertical cross-sectional view of left ventricle 10 and left atrium 22 of heart 14 in which a splint 16 has been placed. As shown in FIG. 9, splint 16 includes an alternative anchor 26. The anchor 26 is preferably an elongate member having a length as shown in FIG. 9 substantially greater than its width (not shown). Anchor bar 26 might be used to reduce the radius or cross-sectional area of the left ventricle in an instance where there is generalized enlargement of left ventricle 10 such as in idiopathic dilated cardiomyopathy. In such an instance, bar anchor 26 can distribute forces more widely than anchor 20.
[0081] FIGS. 20 and 21 are side views of a hinged anchor 28 which could be substituted for anchors 20 in undeployed and deployed positions respectively. Anchor 28 as shown in FIG. 20 includes two legs similar to bar anchor 26. Hinged anchor 28 could include additional legs and the length of those legs could be varied to distribute the force over the surface of the heart wall. In addition there could be webbing between each of the legs to give anchor 28 an umbrella-like appearance. Preferably the webbing would be disposed on the surface of the legs which would be in contact with the heart wall.
[0082] FIG. 22 is a cross-sectional view of a capture ball anchor 30. Capture ball anchor 30 can be used in place of anchor 20. Capture ball anchor 30 includes a disk portion 32 to distribute the force of the anchor on the heart wall, and a recess 34 for receiving a ball 36 affixed to an end of tension member 18. Disk 32 and recess 34 include a side groove which allows tension member 38 to be passed from an outside edge of disk 32 into recess 34. Ball 36 can then be advanced into recess 34 by drawing tension member 18 through an opening 38 in recess 34 opposite disk 32.
[0083] FIG. 23 is a perspective view of a cross bar anchor 40. The cross bar anchor 40 can be used in place of anchors 20. The anchor 40 preferably includes a disk or pad portion 42 having a cross bar 44 extending over an opening 46 in pad 42. Tension member 18 can be extended through opening 46 and tied to cross bar 42 as shown.
[0084] In use, the various embodiments of the present invention are placed in or adjacent the human heart to reduce the radius or cross-section area of at least one chamber of the heart. This is done to reduce wall stress or tension in the heart or chamber wall to slow, stop or reverse failure of the heart. In the case of the splint 16 shown in FIG. 1, a canula can be used to pierce both walls of the heart and one end of the splint can be advanced through the canula from one side of the heart to the opposite side where an anchor can be affixed or deployed. Likewise, an anchor is affixed or deployed at the opposite end of splint 16.
[0085] FIG. 24 is a vertical cross-sectional view of a chamber 10 of a heart 14. A needle 60 having a stylet inserted therethrough is inserted through chamber 10. FIG. 25 shows needle 60 disposed in heart 40 as shown in FIG. 24. In FIG. 25, stylet 63 has been removed. A tension member 64 having a flexible loader 66 attached to one end of tension member 64, is threaded through needle 60 and an anchor 68.
[0086] As shown in FIG. 25, tension member 64 includes a generally elongate cylindrical shaft 70 having two generally cylindrical ends 72. Ends 72 preferably have a greater diameter than shaft 70. Also shown in FIG. 25 is a perspective view of anchor 68 showing an opening 73 extending through anchor 68. Opening 73 includes a first cylindrically shaped opening 74 extending entirely through anchor 68. The diameter of opening 74 is preferably slightly greater than the diameter of end 72 of tension member 64. A groove 76 having a width preferably slightly greater than that of shaft 70 of tension member 64 extends from opening 74 to a generally cylindrical opening 78. Generally cylindrical opening 78 has a diameter approximately equal to end 72. Unlike opening 74, however, opening 78 includes a reduced base opening 80 which has a width approximately equal to that of groove 76. The width of the opening 80 is also less than the diameter of end 72 of tension member 64.
[0087] It can be appreciated that tension member 64 can be advanced through opening 74 until shaft 70 is disposed therein. Shaft 70 can be then slid transversely through groove 76. Tension member 64 can then be advanced further through opening 73 until end portion 72 enters opening 78 and seats against base 80.
[0088] FIG. 26 shows the view of heart 14 shown in FIG. 25. Needle 60 has been removed from heart 14. Tension member 64 has been advanced into chamber 10 and anchor 68 connected thereto is engaging the heart wall. Leader 66 has been advanced through yet another anchor 68 disposed on the opposite side of heart 14.
[0089] FIG. 27 is a view of heart 14 of FIG. 26. Two tension member 64 have been advanced through chamber 10. Each tension member has been seated in respective opening 78 against respective bases 80 to form a splint in a configuration such as that shown in FIG. 9.
[0090] It can be appreciated that each of the other tension member splints configurations can be placed on the heart in a similar manner. It can also be appreciated that anchors 68 could initially be held against the heart and needle 60 advanced through anchors 68 and chamber 10 prior to extending leader 66 through the needle.
[0091] FIG. 28 is a perspective view of a tension member 164 in accordance with the present invention. Tension member 164 is similar to tension member 64 described above in that it has an elongate, generally cylindrical shaft 170 and generally cylindrical ends 172. A lumen, however, extends longitudinally through tension member 164 along axis A.
[0092] FIG. 29 is a perspective view of yet another embodiment of the tension member 264. Tension member 264, is similar to tension member 164, and includes an elongate cylindrical shaft 270 and cylindrical ends 272. Lumens 282, however, extend through ends 272 aligned along axis P.
[0093] FIG. 30 is a vertical, cross-sectional view of left ventricle 10 of heart 14. Anchors 68 have been placed on opposite sides of heart 14. A needle 160 extends through the lumen of tension member 164, left ventricle 10 and openings 73 in anchors 68. It can be appreciated that tension member 64 can be advanced through anchors 68 and left ventricle 10 and be seated within openings 78 as described above with respect to tension member 64.
[0094] FIG. 31 is a vertical, cross-sectional view of left ventricle 10 of heart 14. A needle 60 has been advanced through the wall of left ventricle 10 and a guidewire 162 has been advanced through needle 60.
[0095] FIG. 32 is the same view of heart 14 as shown in FIG. 32. Needle 60, however, has been removed from heart 14 while guidewire 162 remains in position. Anchors 68 have been placed on guidewire 162, on opposite sides of left ventricle 10. Tension member 264 has been threaded onto guidewire 162 through lumens 282. It can be appreciated that as discussed above with respect to tension member 164 above, tension member 264 can be advanced through left ventricle 10 such that ends 272 of tension member 264 seat in respective openings 78 against base 80.
[0096] FIG. 33 is a vertical, cross-sectional view of left ventricle 10 of heart 14. In FIG. 34, flexible tension member 364 has been connected to a needle 360. Needle 360 is shown being advanced into left ventricle 10 through a ventricle wall.
[0097] FIG. 34 is the same view of heart 14 as shown in FIG. 33 except that tension member 364 has been advanced entirely through left ventricle 10 and anchors 68. Knots 384 have been tied at the ends of tension member 364 to prevent the ends of tension member 364 from passing through opening 73 of anchors 68.
[0098] It can be appreciated that the methods described above to advance the tension members through the ventricles can be repeated to advance the desired number of tension members through the ventricle for a particular configuration. The length of the tension members can be determined based upon the size and condition of the patient's heart. It should also be noted that although the left ventricle has been referred to here for illustrative purposes, that the apparatus and methods of this invention can also be used to splint multiple chambers of a patient's heart as well as the right ventricle or either atrium.
[0099] FIG. 35 is a vertical cross-section of left ventricle 10 of heart 14. Disposed about heart 14 is a band 716. Band 716 is shown as being sized relative to the heart such that the heart's radius or cross-sectional area in a plane parallel to the length of the band is reduced relative to the radius at that location prior to placement of the band on the heart. The length of the heart perpendicular to the band is also increased. The band may be formed from a continuous ribbon of elastomeric material or from other biocompatible materials which are sufficiently strong to provide the desired effect of heart radius reduction and lengthening.
[0100] FIG. 36 is a view of a cylinder or idealized heart chamber 48 which is used to illustrate the reduction of wall stress in a heart chamber as a result of deployment of the splint in accordance with the present invention. The model used herein and the calculations related to this model are intended merely to illustrate the mechanism by which wall stress is reduced in the heart chamber. No effort is made herein to quantify the actual reduction which would be realized in any particular in vivo application.
[0101] FIG. 37 is a view of the idealized heart chamber 48 of FIG. 36 wherein the chamber has been splinted along its length L such that a “figure eight” cross-section has been formed along the length thereof. It should be noted that the perimeter of the circular transverse cross-section of the chamber in FIG. 36 is equal to the perimeter of the figure eight transverse cross-section of FIG. 37. For purposes of this model, opposite lobes of the figure in cross-section are assumed to be mirror images.
[0102] FIG. 38 shows various parameters of the FIG. 1 cross-section of the splinted idealized heart chamber of FIG. 37. Where l is the length of the splint between opposite walls of the chamber, R2is the radius of each lobe, θ is the angle between the two radii of one lobe which extends to opposite ends of the portion of the splint within chamber 48 and h is the height of the triangle formed by the two radii and the portion of the splint within the chamber 48 (R1is the radius of the cylinder of FIG. 36). These various parameters are related as follows:
[0103] h=R2COS(θ/2)
[0104] l=2R2SIN(θ/2)
[0105] R2=R1π/(2π−θ)
[0106] From these relationships, the area of the figure eight cross-section can be calculated by:
[0107] A2=2π(R2)2(1−θ/2π)+hl
[0108] Where chamber 48 is unsplinted as shown in FIG. 36 A1, the original cross-sectional area of the cylinder is equal to A2where θ=180°, h=0 and l=2R2. Volume equals A2times length L and circumferential wall tension equals pressure within the chamber times R2times the length L of the chamber.
[0109] Thus, for example, with an original cylindrical radius of four centimeters and a pressure within the chamber of 140 mm of mercury, the wall tension T in the walls of the cylinder is 104.4 newtons. When a 3.84 cm splint is placed as shown in FIGS. 37 and 38 such that l=3.84 cm, the wall tension T is 77.33 newtons.
[0110] FIGS. 39 and 40 show a hypothetical distribution of wall tension T and pressure P for the figure eight cross-section. As θ goes from 180° to 0°, tension Tsin the splint goes from 0 to a 2T load where the chamber walls carry a T load.
[0111] In yet another example, assuming that the chamber length L is a constant 10 cm, the original radius R1is 4 cm, at a 140 mmHg the tension in the walls is 74.7 N. If a 4.5 cm splint is placed such that l=4.5 cm, the wall tension will then be 52.8 N.
[0112] It will be understood that this disclosure in many respects, is only illustrative. Changes may be made in details, particularly in matters of shape, size, material, and arrangement of parts without exceeding the scope of the invention. Accordingly, the scope of the invention is as defined in the language of the appended claims.
Claims
What is claimed is:
1. A kit for treating a heart, comprising:
a guide mechanism having a first end and a second end, said guide mechanism being capable of extending through a heart wall surrounding a heart chamber so that each end of the guide mechanism is external the chamber;
an elongate member having a first end and a second end, said elongate member advanced through the guide mechanism such that, when the guide mechanism extends through the heart wall, the first end and the second end of the elongate member are external the heart chamber; and
an anchoring device capable of coupling the elongate member to the chamber at exterior portions of the chamber.
2. The kit of claim 1, wherein the guide mechanism includes a hollow needle.
3. The kit of claim 2, wherein the hollow needle defines a lumen between the first and second ends of the hollow needle and the elongate member is configured to be advanced through the lumen.
4. The kit of claim 1, wherein the guide mechanism is configured to be removed from the heart chamber after the elongate member is advanced through the guide mechanism and prior to coupling at least one end of the elongate member to the heart chamber.
5. The kit of claim 1, further comprising a stylet capable of positioning within the guide mechanism as the guide mechanism extends through a heart wall.
6. The kit of claim 1, further comprising a leader member configured to be attached to one of the first end and the second end of the elongate member for advancing the elongate member through the guide mechanism and across the heart chamber.
7. The kit of claim 6, wherein the leader member is flexible.
8. The kit of claim 6, wherein the leader member is capable of being removed from the elongate member.
9. The kit of claim 1, wherein the anchoring device includes a first anchoring member and a second anchoring member capable of coupling the elongate member to the chamber at exterior portions of the chamber corresponding respectively to the first end and the second end of the elongate member.
10. The kit of claim 9, wherein the first and second anchoring members include anchor pads capable of engaging a wall of the heart chamber.
11. The kit of claim 10, wherein each of the anchor pads defines an aperture, the first and second ends of the elongate member being configured to extend at least partially through said apertures.
12. The kit of claim 10, wherein the anchor pads have a disc-like shape.
13. The kit of claim 9, wherein the first and second anchoring members are capable of being secured to the elongate member.
14. The kit of claim 9, wherein the first end of the elongate member is at a proximal end of the elongate member and the first anchoring member is attached to the first end of the elongate member prior to advancing the elongate member through the guide mechanism.
15. The kit of claim 9, wherein the elongate member has a predetermined length between the first anchoring member and the second anchoring member.
16. The kit of claim 1, wherein the elongate member includes a tension member configured to extend transverse the heart chamber.
17. The kit of claim 1, wherein the elongate member, when coupled to the chamber via the anchoring device, is configured to alter a shape of the chamber during at least a portion of a cardiac cycle.
18. The kit of claim 1, wherein the elongate member, when coupled to the chamber via the anchoring device, is configured to draw portions of a wall of the chamber toward each other during at least a portion of a cardiac cycle.
19. The kit of claim 18, wherein the elongate member, when coupled to the chamber via the anchoring device, is further configured such that the portions of the wall drawn together remain in a non-contacting relationship.
20. The kit of claim 1, wherein the elongate member, when coupled to the chamber via the anchoring device, is configured to reduce a radius of the chamber during at least a portion of a cardiac cycle.
21. The kit of claim 1, wherein the elongate member is flexible.
22. The kit of claim 1, further comprising a plurality of elongate members configured to be coupled to exterior portions of the heart chamber.
23. A kit for treating a heart, comprising:
a hollow needle having a first end and a second end and a lumen therebetween, the needle being capable of penetrating a heart wall surrounding a heart chamber and extending through the chamber such that each end of the needle is external the chamber;
a stylet capable of positioning within the needle as the needle extends through a heart wall;
an elongate member having a first end and a second end opposite the first end, said elongate member advanced through the lumen of the needle such that the first end and the second end of the elongate member are external the heart chamber;
a leader member attached to the first end of the elongate member for advancing the elongate member through the needle and across the heart chamber; and
a first anchoring member and a second anchoring member capable of coupling the elongate member to the chamber at exterior portions of the chamber corresponding respectively to the first end and the second end of the elongate member.
24. The kit of claim 23, wherein the needle is configured to be removed from the heart chamber after the elongate member is advanced through the lumen of the hollow needle and prior to coupling at least one end of the elongate member to the heart chamber.
25. The kit of claim 23, wherein the leader member is flexible.
26. The kit of claim 23, wherein the leader member is capable of being removed from the elongate member.
27. The kit of claim 23, wherein the first and second anchoring members include anchor pads capable of engaging a wall of the heart chamber.
28. The kit of claim 27, wherein each of the anchor pads defines an aperture, the first and second ends of the elongate member being configured to extend at least partially through said apertures.
29. The kit of claim 27, wherein the anchor pads have a disc-like shape.
30. The kit of claim 23, wherein the first and second anchoring members are capable of being secured to the elongate member.
31. The kit of claim 23, wherein the elongate member includes a tension member configured to extend transverse the heart chamber.
32. The kit of claim 23, wherein the elongate member, when coupled to the chamber via the anchoring members, is configured to alter a shape of the chamber during at least a portion of a cardiac cycle.
33. The kit of claim 23, wherein the elongate member, when coupled to the chamber via the anchoring members, is configured to draw portions of a wall of the chamber toward each other during at least a portion of a cardiac cycle.
34. The kit of claim 33, wherein the elongate member, when coupled to the chamber via the anchoring members, is further configured such that the portions of the wall drawn together remain in a non-contacting relationship.
35. The kit of claim 23, wherein the elongate member, when coupled to the chamber via the anchoring members, is configured to reduce a radius of the chamber during at least a portion of a cardiac cycle.
36. The kit of claim 23, wherein the elongate member is flexible.
37. The kit of claim 23, wherein the second end of the elongate member is at a proximal end of the elongate member and the second anchoring member is attached to the second end of the elongate member prior to advancing the elongate member through the lumen of the needle.
38. The kit of claim 23, wherein the elongate member has a predetermined length between the first anchoring member and the second anchoring member.
39. The kit of claim 23, further comprising a plurality of elongate members configured to be coupled to exterior portions of the heart chamber.
Patent Citations (96)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| USRe.34021 | 1992-08-01 | Mueller et al. | Applicant |
| US4192293 | 1980-03-01 | Asrican | Applicant |
| US4261342 | 1981-04-01 | Aranguren Duo | Applicant |
| US4372293 | 1983-02-01 | Vijil-Rosales | Applicant |
| US4409974 | 1983-10-01 | Freedland | Applicant |
| US4536893 | 1985-08-01 | Parravicini | Applicant |
| US4690134 | 1987-09-01 | Snyders | Applicant |
| US4936857 | 1990-06-01 | Kulik | Applicant |
| US4944753 | 1990-07-01 | Burgess et al. | Applicant |
| US4960424 | 1990-10-01 | Grooters | Applicant |
| US4997431 | 1991-03-01 | Isner et al. | Applicant |
| US5106386 | 1992-04-01 | Isner et al. | Applicant |
| US5131905 | 1992-07-01 | Grooters | Applicant |
| US5169381 | 1992-12-01 | Snyders | Applicant |
| US5192314 | 1993-03-01 | Daskalakis | Applicant |
| US5250049 | 1993-10-01 | Michael | Applicant |
| US5284488 | 1994-02-01 | Sideris | Applicant |
| US5385528 | 1995-01-01 | Wilk | Applicant |
| US5433727 | 1995-07-01 | Sideris | Applicant |
| US5450860 | 1995-09-01 | O'Connor | Applicant |
| US5452733 | 1995-09-01 | Sterman et al. | Applicant |
| US5458574 | 1995-10-01 | Machold et al. | Applicant |
| US5496305 | 1996-03-01 | Kittrell et al. | Applicant |
| US5509428 | 1996-04-01 | Dunlop | Applicant |
| US5533958 | 1996-07-01 | Wilk | Applicant |
| US5571215 | 1996-11-01 | Sterman et al. | Applicant |
| US5584803 | 1996-12-01 | Stevens et al. | Applicant |
| US5593424 | 1997-01-01 | Northrup, III | Applicant |
| US5682906 | 1997-11-01 | Sterman et al. | Applicant |
| US5702343 | 1997-12-01 | Alferness | Applicant |
| US5718725 | 1998-02-01 | Sterman et al. | Applicant |
| US5800334 | 1998-09-01 | Wilk | Applicant |
| US5800528 | 1998-09-01 | Lederman et al. | Applicant |
| US5814097 | 1998-09-01 | Sterman et al. | Applicant |
| US5849005 | 1998-12-01 | Garrison et al. | Applicant |
| US5855614 | 1999-01-01 | Stevens et al. | Applicant |
| US5865791 | 1999-02-01 | Whayne et al. | Applicant |
| US5902229 | 1999-05-01 | Tsitlik et al. | Applicant |
| US5957977 | 1999-09-01 | Melvin | Applicant |
| US5961440 | 1999-10-01 | Schweich, Jr. et al. | Applicant |
| US5971910 | 1999-10-01 | Tsitlik et al. | Applicant |
| US5984857 | 1999-11-01 | Buck et al. | Applicant |
| US6024096 | 2000-02-01 | Buckberg | Applicant |
| US6024756 | 2000-02-01 | Huebsch et al. | Applicant |
| US6045497 | 2000-04-01 | Schweich, Jr. et al. | Applicant |
| US6050936 | 2000-04-01 | Schweich, Jr. et al. | Applicant |
| US6059715 | 2000-05-01 | Schweich, Jr. et al. | Applicant |
| US6071303 | 2000-06-01 | Laufer | Applicant |
| US6077214 | 2000-06-01 | Mortier et al. | Applicant |
| US6077218 | 2000-06-01 | Alferness | Applicant |
| US6079414 | 2000-06-01 | Roth | Applicant |
| US6085754 | 2000-02-01 | Alferness et al. | Applicant |
| US6095968 | 2000-08-01 | Snyders | Applicant |
| US6110100 | 2000-08-01 | Talpade | Applicant |
| US6117159 | 2000-09-01 | Huebsch et al. | Applicant |
| US6123662 | 2000-09-01 | Alferness et al. | Applicant |
| US6125852 | 2000-10-01 | Stevens et al. | Applicant |
| US6126590 | 2000-10-01 | Alferness | Applicant |
| US6155968 | 2000-12-01 | Wilk | Applicant |
| US6155972 | 2000-12-01 | Nauertz et al. | Applicant |
| US6162168 | 2000-12-01 | Schweich, Jr. et al. | Applicant |
| US6165119 | 2000-12-01 | Schweich, Jr. et al. | Applicant |
| US6165120 | 2000-12-01 | Schweich, Jr. et al. | Applicant |
| US6165121 | 2000-12-01 | Alferness | Applicant |
| US6165122 | 2000-12-01 | Alferness | Applicant |
| US6169922 | 2001-01-01 | Alferness et al. | Applicant |
| US6174279 | 2001-01-01 | Girard | Applicant |
| US6179791 | 2001-01-01 | Krueger | Applicant |
| DE29619294 | 1987-08-01 | Applicant | |
| DE3614292 | 1987-11-01 | Applicant | |
| DE4234127 | 1994-05-01 | Applicant | |
| EP583012 | 1994-02-01 | Applicant | |
| WO91/19465 | 1991-12-01 | Applicant | |
| WO95/06447 | 1995-03-01 | Applicant | |
| WO95/16476 | 1995-06-01 | Applicant | |
| WO96/04852 | 1996-02-01 | Applicant | |
| WO96/40356 | 1996-12-01 | Applicant | |
| WO97/24101 | 1997-07-01 | Applicant | |
| WO98/03213 | 1998-01-01 | Applicant | |
| WO98/14136 | 1998-04-01 | Applicant | |
| WO98/18393 | 1998-05-01 | Applicant | |
| WO98/26738 | 1998-06-01 | Applicant | |
| WO98/29041 | 1998-07-01 | Applicant | |
| WO98/32382 | 1998-07-01 | Applicant | |
| WO99/13777 | 1999-03-01 | Applicant | |
| WO99/30647 | 1999-06-01 | Applicant | |
| WO99/44534 | 1999-09-01 | Applicant | |
| WO99/44680 | 1999-09-01 | Applicant | |
| WO99/52470 | 1999-10-01 | Applicant | |
| WO/13722 | 2000-03-01 | Applicant | |
| WO/18320 | 2000-04-01 | Applicant | |
| WO/28912 | 2000-05-01 | Applicant | |
| WO/36995 | 2000-06-01 | Applicant | |
| WO/45735 | 2000-08-01 | Applicant | |
| WO/62727 | 2000-10-01 | Applicant | |
| WO1/03608 | 2001-01-01 | Applicant |
Non-Patent Literature (64)
- Edie, M.D. et al., “Surgical repair of single ventricle,”The Journal of Thoracic and Cardiovascular Surgery, vol. 66, No. 3, Sep., 1973, pp. 350-360.Applicant
- McGoon, M.D. et al., “Correction of the univentricular heart having two atrioventricular valves,” The Journal of Thoracic and Cardiovascular Surgery, vol. 74, No. 2, Aug., 1977, pp.218-226.Applicant
- Lev, M.D., et al., “Single (Primitive) Ventricle,” Circulation, vol. 39, May, 1969, pp. 577-591.Applicant
- Westaby with Bosher, “Landmarks in Cardiac Surgery,” 1997, pp. 198-199.Applicant
- Shumacher, “Cardiac Aneurysms,” The Evolution of Cardiac Surgery, 1992, pp. 159-165.Applicant
- Feldt, M.D., “Current status of the septation procedure for univentricular heart,” The Journal of Thoracic and Cardiovascular Surgery, vol. 82, No. 1, Jul., 1981, pp. 93-97.Applicant
- Doty, M.D., “Septation of the univentricular heart,” The Journal of Thoracic and Cardiovascular Surgery, vol. 78, No. 3, Sep., 1979, pp. 423-430.Applicant
- Carpentier et al., “Myocardial Substitution with a Stimulated Skeletal Muscle: First Successful Clinical Case,” Letter to the Editor, p. 1267, Sep. 25, 1996.Applicant
- Ianuzzo et al., “Preservation of the Lattisimus Dorsi Muscle During Cardiomyoplasty Surgery,” J. Card. Surg., 1996:11:99-108.Applicant
- Ianuzzo et al., “On Preconditioning of Skeletal Muscle: Application to Dynamic Cardiomyoplasty,” Invited Commentary, J. Card. Surg., 1996:11:109-110.Applicant
- Chachques et al., “Latissimus Dorsi Dynamic Cardiomyoplasty,” Ann. Thorac. Surg., 1989:47:600-604.Applicant
- Moreira et al., “Latissimus Dorsi Cardiomyoplasty in the Treatment of Patients with Dilated Cardiomyopathy,” Supplement IV Circulation, Sep. 25, 1996, 7 pgs.Applicant
- Lucas et al., “Long-Term Follow-Up (12 to 35 Weeks) After Dynamic Cardiomyoplasty,” JACC, vol. 22, No. 3 Sep. 1993:758-67.Applicant
- Batista et al., “Partial Left Ventriculectomy to Improve Left Ventricular Function in End-Stage Heart Disease,” J. Card. Surg., 1996:11-96-98.Applicant
- “Congestive Heart Failure in the United States: A New Epidemic” Data Fact Sheet, National Heart, Lung, and Blood Institute, National Institutes of Health, Dec. 9, 1996, pp. 1-6.Applicant
- Kormos et al., “Experience with Univentricular Support in Mortally Ill Cardiac Transplant Candidates,” Ann. Thorac. Surg., 1990:49:261-71.Applicant
- Wampler et al., “Treatment of Cardiogenic Shock with the Hemopump Left Ventricular Assist Device,” Ann. Thorac. Surg., 1991:52:506-13.Applicant
- McCarthy et al., “Clinical Experience with the Novacor Ventricular Assist System,” J. Thorac. Cardiovasc. Surg., 1991:102-578-87.Applicant
- Burnett et al., “Improved Survival After Hemopump Insertion in Patients Experiencing Postcardiotomy Cardiogenic Shock During Cardiopulmonary Bypass,” From the Section of Transplantation, Division of Cardiovascular Surgery, Texas Heart Institute and St. Luke's Episcopal Hospital, Houston, Texas, dated even with or prior to Jan. 2, 1997, pp. 626-628.Applicant
- Phillips et al., “Hemopump Support for the Failing Heart,” From the Department of Cardiovascular Medicine and Surgery, Mercy Hospital Medical Center, Des Moines, Iowa, date even with or prior to Jan. 2, 1997, pp. 629-631.Applicant
- Deeb et al., “Clinical Experience with the Nimbus Pump,” From the University of Michigan Medical Center Section of Thoracic Surgery and Division of Cardiology, Ann Arbor, Michigan, date even with or prior to Jan. 2, 1997, pp. 632-636.Applicant
- Bearnson et al., “Development of a Prototype Magnetically Suspended Rotor Ventricular Assist Device,” ASAIO Journal, 1996, pp. 275-280.Applicant
- Sakakibara et al., “A Muscle Powered Cardiac Assist Device for Right Ventricular Support: Total Assist or Partial Assist?,” Trans. Am.Soc. Artif. Intern. Organs, vol. XXXVI, 1990, pp. 372-375.Applicant
- Medtronic, Inc. 1996 Annual Shareholders Report, 79 pages.Applicant
- ABIOMED, Inc. Annual Report 1996, 32 pages.Applicant
- Press Release dated Sep. 16, 1996, “ABIOMED Wins $8.5 Million Federal Contract to Qualify its Artificial Heart for Human Trials,” 5 pages.Applicant
- Press Release dated Sep. 26, 1996, “ABIOMED's Temporary Artificial Heart System Reaches 200 U.S. Medical Center Milestone,” 1 page.Applicant
- Press Release dated May 17, 1996, “ABIOMED Receives FDA Approval to Expand Indications for Use of Cardiac Assist System,” 1 page.Applicant
- Press Release dated Oct. 3, 1995, “ABIOMED Wins $4.35 Million Contract from the National Heart, Lung and Blood Institutes to Develop Implantable Heart Booster,” 1 page.Applicant
- Press Release dated Sep. 29, 1995, “ABIOMED Wins NIH Grant to Develop Calcification-Resistant Plast Heart Valve,” 1 page.Applicant
- Press Release dated Aug. 25, 1995, “ABIOMED Wins Research Grant from NIH to Develop Suturing Instrument for Abdominal surgery, ” 1 page.Applicant
- Press Release dated Aug. 11, 1995, “ABIOMED Receives Grant from NIH to Develop Disposable Bearingless Centrifugal Blood Pump,” 1 page.Applicant
- Press Release dated Jun. 9, 1995, “ABIOMED Receives Grant from National Institutes of Health to Develop a Laser Welding Technique for Tissue Repair,” 1 page.Applicant
- Press Release dated Apr. 27, 1995, “ABIOMED's Temporary Artificial Heart System Reaches 1,000 Patient Milestone; BVS-5000 in More Than 100 U.S. Medical Centers,” 1 page.Applicant
- “Reversible Cardiomyopathy,” Thoratec's Heartbeat, vol. 10.2, Aug. 1996, 4 pages.Applicant
- Tsai et al., “Surface Modifying Additives for Improved Device-Blood Compatibility,” ASAIO Journal, 1994, pp. 619-624.Applicant
- Farrar et al., “A New Skeletal Muscle Linear-Pull Energy Convertor as a Power Source for Prosthetic Support Devices,” The Journal of Heart & Lung Transplantation, vol. 11, No. 5, Sep., 1992, pp. 341-349.Applicant
- Brochure entitled “Thoratec Ventricular Assist Device System—Because Heart Patients Come in All Sizes,” date even with or prior to Jan. 2, 1997, 5 pages.Applicant
- Press Release dated Oct. 3, 1994, “Heartmate System Becomes First Implantable Cardiac-Assist Device to be Approved for Commercial Sale in the U.S.,” 2 pages.Applicant
- Bocchi et al., “Clinical Outcome after Surgical Remodeling of Left Ventricle in Candidates to Heart Transplantation with Idiopathic Dilated Cardiomypathy—Short Term Results,” date even with or prior to Jan. 2, 1997, 1 page.Applicant
- Bach et al., “Early Improvement in Congestive Heart Failure after Correction of Secondary Mitral Regurgitation in End-Stage Cardiomyopathy,” American Heart Journal, Jun. 1995, pp. 1165-1170.Applicant
- Schuler et al., “Temporal Response of Left Ventricular Performance to Mitral Valve Surgery,” vol. 59, No. 6, Jun. 1979, pp. 1218-1231.Applicant
- Huikuri, “Effect of Mitral Valve Replacement on Left Ventricular Function in Mitral Regurgitation,” Br. Heart J., vol. 49, 1983, pp. 328-333.Applicant
- Pitarys II et al., “Long-Term Effects of Excision of the Mitral Apparatus on Global and Regional Ventricular Function in Humans,” JACC, vol. 15, No. 3, Mar. 1, 1990, pp. 557-563.Applicant
- Bolling et al., “Surgery for Acquired Heart Disease/Early Outcome in Mitral Valve Reconstruction in Patients with End-Stage Cardiomyopathy,” The Journal of Thoracic and Cardiovascular Surgery, vol. 109, No. 4, Apr. 1995, pp. 676-683.Applicant
- Masahiro et al., “Surgery for Acquired Heart Disease/Effects of Preserving Mitral Apparatus on Ventricular Systolic Function in Mitral Valve Operations in Dogs,” The Journal of Thoracic and Cardiovascular Surgery, vol. 106, No. 6, Dec. 1993, pp. 1138-1146.Applicant
- Dickstein et al., “Heart Reduction Surgery: An Analysis of the Impact on Cardiac Function,” The Journal of Thoracic and Cardiovascular Surgery, vol. 113, No. 6, Jun. 1997, 9 pages.Applicant
- McCarthy et al., “Early Results with Partial Left Ventriculectomy,” From the Departments of Thoracic and Cardiovascular Surgery, Cardiology, and Transplant Center, Cleveland Clinic Foundation, Presented at the 77th Annual Meeting of the American Association of Thoracic Surgeons, May 1997, 33 pages.Applicant
- Alonso-Lej, M.D., “Adjustable Annuloplasty for Tricuspid Insufficiency,” The Annals of Thoracic Surgery, vol. 46, No. 3, Sep. 1988, 2 pages.Applicant
- Kurlansky et al., “Adjustable Annuloplasty for Tricuspid Insufficiency,” Ann. Thorac. Surg., 44:404-406, Oct. 1987.Applicant
- Savage, M.D., “Repair of left ventricular aneurysm,” The Journal of Thoracic and Cardiovascular Surgery, vol. 104, No. 3, Sep., 1992, pp. 752-762.Applicant
- Melvin, “Ventricular Radius Reduction Without Restriction: A Computational Analysis,” ASAIO Journal, 45:160-165, 1999.Applicant
- Cox, “Left Ventricular Aneurysms: Pathophysiologic Observations and Standard Resection,” Seminars in Thoracic and Cardiovascular Surgery, vol. 9, No. 2, Apr., 1997, pp. 113-122.Applicant
- Boyd et al., “Triscuspid Annuloplasty,” The Journal of Thoracic Cardiovascular Surgery, vol. 68, No. 3, Sep. 1974, 8 pages.Applicant
- Acorn Cardiovascular, Inc. Abstracts, Nov. 13, 2000.Applicant
- Acorn Cardiovascular Summary, undated, 1 page.Applicant
- “Nation's First ‘Heart Jacket’ Surgery to Treat Heart Failure Performed at HUP; Novel ‘Cardiac Support Device’ Comes to America After Promising Results in Europe,” Jun. 26, 2000, 3 pages.Applicant
- Acorn Cardiovascular Company Overview, 6/2000, 6 pages.Applicant
- Acorn Cardiovascular Company Overview, undated, 2 pages.Applicant
- Acorn Cardiovascular Executive Summary, May 2000, 7 pages.Applicant
- Acorn Cardiovascular Highlights, Abstracts, Mar. 10, 1999.Applicant
- Acorn Cardiovascular Highlights, Abstracts, Apr. 19, 1999.Applicant
- Acorn Cardiovascular Highlights, Abstracts, Oct. 1, 1999.Applicant
- Acorn Cardiovascular Highlights, Abstracts, Nov. 9, 1999.Applicant